Abby Stork
Urogynecology and Reconstructive Pelvic Surgery · Overland Park, KSNPI 1114459260
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,542 of the $2,232 with a category attached, or 69.1%. Coloplast accounts for 61.0% of it on its own, with 5 other manufacturers making up the rest.
Across 41 payments — averaging $54.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$1K
- Boston Scientific$317
- Sumitomo Pharma America, Inc.$292
- AbbVie$225
- Applied Medical Resources Corporation$20
- Escala Medical Inc.$16
What the payments were for
- Travel & lodging$69031%
- Food & beverage$1,54269%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 13 | $1,362 |
| Boston Scientific | 4 | $317 |
| Sumitomo Pharma America, Inc. | 10 | $292 |
| AbbVie | 12 | $225 |
| Applied Medical Resources Corporation | 1 | $20 |
| Escala Medical Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$879
- Advantage System$140
- Axonics$133
- GEMTESA$122
- BOTOX$118
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $1,094 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $79 |
| Oxycodone Hcl | 21 | $43 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Overland Park
- Charles ButrickOverland Park$97K
- Erika HunterOverland Park$30K
- Patrick NostiOverland Park$6K
- Cathy DahlLawrence$33K
- Trang PhamWichita$4K
- Simon PattonWichita$1K
- Leslie PageWichita$111
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.